• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

细胞遗传学指标在439例原发性骨髓纤维化患者预后评估中的价值

A study of prognostic value of cytogenetics in patients with primary myelofibrosis

摘要目的 评价细胞遗传学指标对于中国原发性骨髓纤维化(PMF)患者的预后评估价值.方法 回顾性分析439例PMF患者的临床资料,应用Kaplan-Meier、Log-rank、似然比检验和COX回归模型对动态国际预后积分系统(DIPSS)、DIPSS-plus和DIPSS-Chinese进行评估.结果 439例PMF患者中男298例,女141例,中位年龄56(8~83)岁.DIPSS-plus可对中国PMF患者进行准确的危险度分组和预后评估(P<0.01);DIPSS-plus较DIPSS有更准确的预测能力[-2 log似然比分别为989.5(DIPSS-plus)和1001.9(DIPSS),P=0.006].单因素分析显示伴有正常核型、复杂非单体核型、单纯+8和单纯平衡易位核型的患者预后较好,将染色体核型分为预后良好组(正常核型、复杂非单体核型、单纯+8和单纯平衡易位)和预后不良组(其他核型异常).经多因素分析提出了修订的DIPSS-Chinese预后积分系统,各参数赋值如下:DIPSS-Chinese低危组0分,中危组1分,高危组2.5分,不良染色体核型组0.5分,良好组0分.439例患者中低危组(0分)163例,中危-1组(0.5~1分)187例,中危-2组(1.5~2.5分)82例,高危组(3分)7例,各组中位生存期分别为74(95% CI 42~106)、39(95%CI26~52)、12(95%CI1~25)个月,总生存差异具有统计学意义(P<0.01).结论 在中国PMF患者中,DIPSS-plus较DIPSS有更好的预测价值,结合中国患者细胞遗传学特征修订的DIPSS-Chinese可望更好地指导PMF患者分组治疗策略的制定.

更多

abstractsObjective To evaluate the prognostic value of cytogenetics in Chinese with primary myelofibrosis (PMF).Methods Four hundred and thirty-nine Chinese patients with PMF were retrospectively analyzed.The Kaplan-Meier method,the Log-rank test,the likelihood ratio test and the COX proportional hazards regression model were used to evaluate the prognostic scoring systems.Results Four hundred and thirty-nine Chinese patients with PMF were analyzed with a median age of 56 years (range:8-83),including 298 males and 141 females.The DIPSS-plus system could effectively evaluate prognosis in Chinese patients with PMF.There was significantly higher predictive power for survival for the DIPSS-plus group compared with the DIPSS group (P=0.006,-2 log-likelihood ratios of 989.5 and 1001.9 for the DIPSS-plus and DIPSS systems,respectively).Univariate analysis indicated that the patients with a normal karyotype,a complex karyotype that was not a monosomal karyotype,+ 8 only or a balanced translocation only had better survival.Following two cytogenetic risk categories were constructed:favorable karyotype including subiects with a normal karyotype,a complex karyotype that was not a monosomal karyotype,+ 8 only or a balanced translocation only and unfavorable karyotype included all others.The modified DIPSS-Chinese prognostic model was proposed by adopting cytogenetic categories and DIPSS-Chinese risk group.The median survival of patients classified in low risk (163 subjects),intermediate-1 risk (187 subjects),intermediate-2 risk (82 subjects) and high risk (7 subjects) were not reached,74 (95% CI 42-106),39 (95% CI 26-52) and 12(95% CI 1-25)months,respectively,and there was a statistically significant difference in overall survival among the four risk groups (P<0.01).Conclusion The DIPSS-plus had significantly higher predictive power than the DIPSS group in Chinese patients with PMF and the modified DIPSS-Chinese system based on the cytogenetic features of Chinese patients was proposed and worked well for prognostic indication.

More
广告
  • 浏览364
  • 下载204
中华血液学杂志

中华血液学杂志

2014年35卷11期

990-994页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷